Skip to main content
. Author manuscript; available in PMC: 2024 Nov 3.
Published in final edited form as: Crit Care Med. 2023 Nov 3;51(2):267–278. doi: 10.1097/CCM.0000000000005700

TABLE 2.

Univariable and Multivariable Linear Regression Assessing Association of Hemoglobin With Viscoelastic Hemostatic Assay Results in Intracerebral Hemorrhage Patients

Rotational Thromboelastometry Outcome Unadjusted Beta Coefficient
(95% CI) p
Adjusted Beta Coefficient
(95% CI) pa
Thromboelastography Outcome Unadjusted Beta Coefficient
(95% CI) p
Adjusted Beta Coefficient
(95% CI) pa
EXTEM CT (s) 0.26 (−0.71 to 4.79)
p = 0.14
0.17 (−1.95 to 4.28)
p = 0.45
Reaction time (min) 0.06 (−0.05 to 0.15)
p = 0.34
0.03 (−0.08 to 0.12)
p = 0.67
EXTEM CFT (s) 0.40 (0.61–6.85)
p = 0.02
0.49 (1.03–7.71)
p = 0.01
Kinetics time (min) 0.31 (0.09–0.21)
p < 0.0001
0.30 (0.09–0.21)
p < 0.0001
EXTEM alpha (degrees) −0.56 (−1.69 to −0.49)
p = 0.001
−0.59 (−1.79 to −0.49)
p = 0.001
Alpha (degrees) −0.45 (−2.04 to −1.21)
p < 0.0001
−0.44 (−2.06 to −1.17)
p < 0.0001
EXTEM MCF (millimeters) −0.29 (−2.09 to 0.21)
p = 0.11
−0.42 (−2.62 to −0.07)
p = 0.04
Maximum amplitude (millimeters) −0.39 (−1.97 to −1.05)
p < 0.0001
−0.39 (−2.01 to −1.05)
p < 0.0001
EXTEM ML (%) NA NA Lysis index (%) −0.13 (−0.17 to 0.001)
p = 0.05
−0.10 (−0.16 to 0.02)
p = 0.14
INTEM CT (s) 0.03 (−10.78 to 12.99)
p = 0.85
−0.02 (−14.95 to 13.90)
p = 0.94
INTEM CFT (s) −0.13 (−9.34 to 4.48)
p = 0.48
−0.12 (−10.85 to 6.23)
p = 0.58
INTEM alpha (degrees) 0.07 (−0.84 to 1.27)
p = 0.68
0.07 (−1.11 to 1.52)
p = 0.75
INTEM MCF (millimeters) −0.09 (−1.47 to 0.85)
p = 0.59
−0.05 (−1.59 to 1.29)
p = 0.83
INTEM ML (%) NA NA
Fibrinogen assay MCF (millimeters) −0.06 (−2.08 to 1.51)
p = 0.75
0.02 (−2.09 to 2.27)
p = 0.94

CFT = clot formation time, CT = coagulation time, EXTEM = extrinsic pathway assay, INTEM = intrinsic pathway assay, MCF = maximal clot firmness, ML = maximum lysis, NA = not available.

a

Adjusted for age, sex, baseline hematoma size, and antiplatelet medication use.